Resonance Health Ltd (ASX: RHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Resonance Health Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $34.56 million
P/E Ratio 100.00
Dividend Yield N/A
Shares Outstanding 461.15 million
Earnings per share -0.001
Dividend per share N/A
Year To Date Return -49.29%
Earnings Yield 1.00%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Resonance Health Ltd (ASX: RHT)
Latest News

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Here’s why the Resonance Health (ASX:RHT) share price is rocketing 36% today

The company's shares are on fire. Here are the details

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development
Share Market News

Here’s why the Resonance Health (ASX:RHT) share price rocketed

The Resonance Health share price rocketed more than 16% today before closing 5% higher. We take a look at what's…

Read more »

pause button on digital screen representing asx trading pause
Share Market News

Resonance Health (ASX:RHT) announces its share price is in trading halt

The Resonance Health share price was edging higher today before the company announced that it would be entering a trading…

Read more »

rising ASX Telstra share price represented by man jumping in the air for joy looking at mobile phone
Share Market News

The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here’s why.

The Resonance Health (ASX: RHT) share price is soaring up today after the company announced a deal using its artificial…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development
Share Market News

Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today

The Resonance Health Limited (ASX: RHT) share price is shooting 39% higher today after the company announced an important FDA…

Read more »

beat the share market
Share Gainers

Why Afterpay, Creso Pharma, Healius, & Resonance Health shares are storming higher

Afterpay Ltd (ASX:APT) and Healius Ltd (ASX:HLS) shares are two of four storming notably higher on Wednesday. Here's why...

Read more »

beat the share market
Share Market News

Here’s why these 3 ASX shares are trading higher today

Here are 3 ASX shares performing strongly today, providing some indication as to what's pushing the S&P/ASX 200 Index (INDEXASX:XJO)…

Read more »

Healthy Heart
Share Market News

Why the Resonance Health share price is rocketing 20% higher

The Resonance Health Limited (ASX: RHT) share price has rocketed 20% after the company released an announcement this morning.

Read more »

RHT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Resonance Health Ltd

Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

RHT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
11 Aug 2022 $0.08 $0.00 0.00% 274,210 $0.07 $0.08 $0.07
10 Aug 2022 $0.07 $0.00 0.00% 10,000 $0.07 $0.07 $0.07
08 Aug 2022 $0.07 $0.00 0.00% 32,204 $0.07 $0.07 $0.07
04 Aug 2022 $0.07 $0.00 0.00% 7,100 $0.07 $0.07 $0.07
02 Aug 2022 $0.07 $0.00 0.00% 5,777 $0.07 $0.07 $0.07
29 Jul 2022 $0.07 $0.00 0.00% 78,316 $0.07 $0.07 $0.07
25 Jul 2022 $0.08 $0.01 14.71% 315,300 $0.07 $0.08 $0.07
22 Jul 2022 $0.07 $0.00 0.00% 99,230 $0.07 $0.07 $0.07
21 Jul 2022 $0.07 $0.00 0.00% 182,000 $0.07 $0.07 $0.07
20 Jul 2022 $0.07 $0.00 0.00% 28,700 $0.07 $0.07 $0.07
15 Jul 2022 $0.07 $-0.01 -13.33% 397,752 $0.08 $0.08 $0.07
14 Jul 2022 $0.08 $0.00 0.00% 100,000 $0.08 $0.08 $0.08

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Martin Peter Blake Non-Executive DirectorNon-Executive Chairman Oct 2007
Dr Blake brings technical and industry experience to Resonance Health. He has been a Partner of Perth Radiological Clinic since 1997 and is currently the Chairman of that Company. He is Member of Risk Committee.
Mr Mitchell MacDonald Wells Executive DirectorManaging DirectorJoint Company Secretary Feb 2018
Mr Wells has worked as a senior executive and as a Director of several ASX and US Nasdaq listed public companies. He has international project management and legal experience, having worked as a project manager and as a corporate and contracts consultant in Australia, the USA, and the United Kingdom. Mr Wells' career started as a lawyer working in law firms before transitioning to an executive role in the UK as a founding executive of London's bid to host the 2012 Olympic & Paralympic Games. He then worked as a project manager on the redevelopment of The O2 Arena precinct in London, regarded by many as Europe's entertainment precinct. Mitchell returned to Australia in 2008 to take up the role of COO, and ultimately CEO, of ASX listed Amadeus Energy Ltd, which was acquired by US based Lonestar Resources Inc. He then facilitated Lonestar's listing on the US Nasdaq and went on to serve as a Director of the Nasdaq listed parent and as Australia country representative. Mr Wells is also a commercial (aircraft) pilot and has served as Chair of two sizable not-for-profit organizations, including Guildford Grammar School.
Mr Simon Panton Non-Executive Director Oct 2009
Mr Panton has been supporter of FerriScan technology over a number of years and is shareholder of Resonance Health. Mr Panton brings skills in business and marketing having run his own business. He is Member of Risk Committee.
Dr Travis Baroni Non-Executive Director Nov 2016
Mr Baroni has experience across industrial research, commercialisation of technology, asset valuations and investment banking services. He has managed innovation development and technology strategy in a company setting as well as being an investor in early stage investments. He has worked in investment banking, providing advisory services to equity capital market transactions, corporate research and valuations to clients. He is Chairman of Risk Committee.
Mr Nicholas (Nick) Allan Chief Financial OfficerJoint Company Secretary May 2021
-
Ms Liesl Ellies Joint Company Secretary Apr 2022
-
Nicholas (Nick) Allan Chief Financial OfficerJoint Company Secretary
-
Liesl Ellies Joint Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Southam Investments 2003 Pty Ltd (Warwickshire Investment A/C) 73,300,000 15.90%
HSBC Custody Nominees (Australia) Limited 43,293,525 9.39%
Acuity Capital Investment Management Pty Ltd (Acuity Capital Holdings A/C) 20,000,000 4.34%
Ms Alison Virginia Wesley (Wesley Family A/C) 10,000,000 2.17%
Mr Paul John Van Dyk 9,349,700 2.03%
Mr William Murray Thompson 6,658,660 1.44%
Ms Jade Louise Thompson 6,512,759 1.41%
Mr Bruce Alan Stevenson 6,300,000 1.37%
Mr Helmut Rocker 6,250,000 1.36%
Marcolongo Nominees Pty Ltd (Marcolongo Family A/C) 5,186,200 1.12%
The Majobri Holdings Pty Ltd (The Majobri Family A/C) 4,500,000 0.98%
Mr Thomas Psarakis 4,434,777 0.96%
Mr Harish Garg 4,001,245 0.87%
BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient DRP) 3,890,663 0.84%
Dr Martin Peter Blake 3,798,590 0.82%
Mr Vincent Oladele 3,708,052 0.80%
Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) 3,588,012 0.78%
Fullerton Private Capital Pty Limited 3,500,000 0.76%
The University Of Western Australia 3,478,750 0.75%
Neweconomy Com Au Nominees Pty Limited (900 Account) 3,389,575 0.74%

Profile

since

Note